Does therapy with an inhaled combination of fluticasone and salmeterol improve clinical outcomes and compliance with taking asthma medication in patients with asthma?

Trial Profile

Does therapy with an inhaled combination of fluticasone and salmeterol improve clinical outcomes and compliance with taking asthma medication in patients with asthma?

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Fluticasone propionate; Salmeterol; Salmeterol/fluticasone propionate
  • Indications Asthma
  • Focus Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 05 Apr 2012 Official Title amended as reported by Australian New Zealand Clinical Trials Registry record.
    • 05 Apr 2012 Actual initiation date changed from May 2006 to Feb 2007 as reported by Australian New Zealand Clinical Trials Registry record.
    • 29 Aug 2011 Actual initiation date Mar 2006 added as reported by Australian New Zealand Clinical Trials Registry.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top